A Novel Augmented Reality System (ARssist & ARport) for the Assistant Surgeon in Robotic Assisted Surgery:
A Novel Augmented Reality System (ARssist & ARport) for the Assistant Surgeon in Robotic Assisted Surgery: A Pilot Study
Robotic prostatectomy is a surgery for treating localized prostate cancer. The ARssist & ARport system is a novel augmented reality system designed for the assistant surgeon, allowing delivery of augmented reality information. This study aims at evaluating the safety and feasibility of the use of ARssist & ARport system in robotic prostatectomy.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
This is a prospective study to evaluate the clinical feasibility and safety of the ARssist and ARport system during robotic surgery with Robotic surgical System. During the operation, the assistant surgeon will utilize the ARssist & ARport system to assist the chief surgeon. Subjects will receive standard post-operative care. The primary objective of this study is to demonstrate the safety and clinical feasibility of the ARssist and ARport system in helping the patient side surgeon perform laparoscopic tasks during robotic assisted urological surgeries, with primary endpoints being safety data and complications.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Yuen Chun Jeremy TEOH, MD
- Telefonnummer: 35053933
- E-mail: jeremyteoh@surgery.cuhk.edu.hk
Undersøgelse Kontakt Backup
- Navn: Ho Ming Chiris WONG, MBChB
Studiesteder
-
-
-
Hong Kong, Hong Kong
- Rekruttering
- Prince of Wales Hospital
-
Kontakt:
- Jeremy Yuen-Chun TEOH, FRCS(Ed)
- Telefonnummer: 35052625
- E-mail: jeremyteoh@surgery.cuhk.edu.hk
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Patient Inclusion Criteria
- Age >18 years
- Body mass index <35kg/m2
- Suitable for minimally invasive surgery
- Willingness to participate as demonstrated by giving informed consent
- Clinically diagnosed with urological conditions that are indicated for robotic assisted radical prostatectomy with or without lymph node dissection
Patient Exclusion Criteria
- Contraindication to general anaesthesia
- Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
- Untreated active infection
- Uncorrectable coagulopathy
- Presence of another malignancy or distant metastasis
- Emergency surgery
- Vulnerable population (e.g. mentally incapacitated persons)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: ARssist & ARport System
|
The surgery will follow the same steps of a standard robotic assisted radical prostatectomy procedure, with the addition of the ARssist and/or ARport system used by the patient side surgeon. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of intervention-related surgical complication
Tidsramme: On Day 30
|
All post-operative complications within 30 days. Complications will be classified based on the Clavien-Dindo classification of surgical complications |
On Day 30
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Performance of the patient side surgeon
Tidsramme: Perioperative
|
By Global Operative Assessment of Laparoscopic Skills( GOALS) checklist, a 5-item global rating scale scored on a 5-point scale, the higher mark reflect the better performance |
Perioperative
|
|
Specific feedback on the use of the system by patient side surgeon
Tidsramme: Perioperative
|
A customized questionnaire of 10 items on a 5-point Likert scale ; the items included are selected and adopted from the feedback questionnaire designed for a study on HoloLens use in ureteroscopic procedure; by a System Usability Scale; the NASA Task Load Index and the Simulator sickness questionnaire. The higher the marks reflect the better performance |
Perioperative
|
|
Operative Time
Tidsramme: Perioperative
|
The duration of operation |
Perioperative
|
|
Blood Loss
Tidsramme: Perioperative
|
The total amount of blood loss in the operation in ml |
Perioperative
|
|
Hospital Stay
Tidsramme: Perioperative
|
Duration of hospital stay in days |
Perioperative
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Ledende efterforsker: Yuen Chun Jeremy TEOH, MD, Chinese University of Hong Kong
Publikationer og nyttige links
Generelle publikationer
- Sgarbura O, Vasilescu C. The decisive role of the patient-side surgeon in robotic surgery. Surg Endosc. 2010 Dec;24(12):3149-55. doi: 10.1007/s00464-010-1108-9. Epub 2010 May 22.
- Al Janabi HF, Aydin A, Palaneer S, Macchione N, Al-Jabir A, Khan MS, Dasgupta P, Ahmed K. Effectiveness of the HoloLens mixed-reality headset in minimally invasive surgery: a simulation-based feasibility study. Surg Endosc. 2020 Mar;34(3):1143-1149. doi: 10.1007/s00464-019-06862-3. Epub 2019 Jun 18.
- Qian L, Deguet A, Kazanzides P. ARssist: augmented reality on a head-mounted display for the first assistant in robotic surgery. Healthc Technol Lett. 2018 Sep 17;5(5):194-200. doi: 10.1049/htl.2018.5065. eCollection 2018 Oct.
- McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, Nicholl J; Balliol Collaboration; Aronson JK, Barkun JS, Blazeby JM, Boutron IC, Campbell WB, Clavien PA, Cook JA, Ergina PL, Feldman LS, Flum DR, Maddern GJ, Nicholl J, Reeves BC, Seiler CM, Strasberg SM, Meakins JL, Ashby D, Black N, Bunker J, Burton M, Campbell M, Chalkidou K, Chalmers I, de Leval M, Deeks J, Ergina PL, Grant A, Gray M, Greenhalgh R, Jenicek M, Kehoe S, Lilford R, Littlejohns P, Loke Y, Madhock R, McPherson K, Meakins J, Rothwell P, Summerskill B, Taggart D, Tekkis P, Thompson M, Treasure T, Trohler U, Vandenbroucke J. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009 Sep 26;374(9695):1105-12. doi: 10.1016/S0140-6736(09)61116-8.
- Barkun JS, Aronson JK, Feldman LS, Maddern GJ, Strasberg SM; Balliol Collaboration; Altman DG, Barkun JS, Blazeby JM, Boutron IC, Campbell WB, Clavien PA, Cook JA, Ergina PL, Flum DR, Glasziou P, Marshall JC, McCulloch P, Nicholl J, Reeves BC, Seiler CM, Meakins JL, Ashby D, Black N, Bunker J, Burton M, Campbell M, Chalkidou K, Chalmers I, de Leval M, Deeks J, Grant A, Gray M, Greenhalgh R, Jenicek M, Kehoe S, Lilford R, Littlejohns P, Loke Y, Madhock R, McPherson K, Rothwell P, Summerskill B, Taggart D, Tekkis P, Thompson M, Treasure T, Trohler U, Vandenbroucke J. Evaluation and stages of surgical innovations. Lancet. 2009 Sep 26;374(9695):1089-96. doi: 10.1016/S0140-6736(09)61083-7.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- CRE 2025.896
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .